FDA Clears Caretaker Medical’s Wireless Platform for Continuous Noninvasive Blood Pressure and Hemodynamic Monitoring
We are excited to announce the U.S. Food and Drug Administration (FDA) clearance of the company’s next-generation VitalStream™ wireless blood pressure and hemodynamic monitoring platform.
Continuous monitoring of blood pressure is of great importance to detect and treat dynamic changes. Traditionally, blood pressure is measured intermittently with traditional cuffs that miss dangerous blood pressure changes, or it is measured continuously with an invasive arterial line, which is costly, requires a skilled clinician, and is difficult to use. VitalStream was designed to eliminate monitoring gaps associated with intermittent spot-check hemodynamic and vital sign measurements.
The VitalStream wireless platform expands the company’s clinically validated PDA™ waveform analysis technology and AI algorithms to measure blood pressure and hemodynamic parameters with every heartbeat, providing an uninterrupted stream of real-time data that eliminates “blind spots” between manual spot-check measurements, without limiting patient mobility. Read our feature in BusinessWire.
Learn more about VitalStream today.
More medical news and events
Caretaker Medical Awarded the Grand Prize in NIH RADx Tech for Maternal Health Challenge
Caretaker Medical, a digital health company focused on developing hemodynamic monitoring devices, today announced that it has been awarded the $525,000 grand prize in the…
VitalStream offers continuous hemodynamic monitoring solution amid IV fluid shortage
Philadelphia, PA – October 9, 2024 – Caretaker Medical, a pioneer in advanced hemodynamic monitoring technology, is highlighting the critical role of its VitalStream solution…
BP cuff, A-line or VitalStream noninvasive hemodynamic monitor?
Should you use a blood pressure cuff, arterial line or VitalStream to monitor your perioperative patients? Learn the about the strengths and weaknesses of each….